The prognosis of severe lupus nephritis based on the Modification of Diet in Renal Disease (MDRD) Study estimated glomerular filtration rate

Lupus

Volumn 20, Issue 3, 2011, Pages 256-264

  Patel, S B ^a   Korbet, S M ^a   Lewis, E J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

estimated glomerular filtration rate; prognosis; severe lupus nephritis

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; CYCLOPHOSPHAMIDE; PREDNISONE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET THERAPY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS; CREATININE; CYCLOPHOSPHAMIDE; DIET; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MIDDLE AGED; PREDNISONE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958715871     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310385267     Document Type: Article

References (27)

1. Austin HA3, Boumpas DT, Vaughan EM, Balow JE Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994 ; 45: 544-550. (Pubitemid 24065091)
2. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M., Evans J., Rohde RD for the Lupus Nephritis Collaborative Study Group. Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis 2000 ; 35: 904-914. (Pubitemid 30238204)
3. Levey AS, Lan SP, Corwin HL, et al. for the Lupus Nephritis Collaborative Study Group. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Internal Med 1992 ; 116: 114-123.
4. Mok CC Prognostic factors in lupus nephritis. Lupus 2005 ; 14: 39-44. (Pubitemid 40216066)
5. Stevens LA, Coresh J., Greene T., Levey AS Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006 ; 354: 2473-2483. (Pubitemid 43855050)
6. Wang X., Lewis J., Appel L., et al. Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. J Am Soc Nephrol 2006 ; 17: 2900-2909. (Pubitemid 44484681)
7. Balow JE Clinical presentation and monitoring of lupus nephritis. Lupus 2005 ; 14: 25-30. (Pubitemid 40216064)
8. Boumpas DT, Balow JE Outcome criteria for lupus nephritis trials: a critical overview. Lupus 1998 ; 7: 622-629. (Pubitemid 29008229)
9. Leung YY, Lo KM, Tam LS, Szeto CC, Li EK, Kun EW Estimation of glomerular filtration rate in patients with systemic lupus erythematosus. Lupus 2006 ; 15: 276-281. (Pubitemid 43828803)
10. Karstila K., Harmoinen AP, Lehtimaki TJ, Korpela MM, Mustonen JT, Saha HH Measurement of the kidney function in patients with rheumatoid arthritis: plasma Cystatin C versus 51Cr-EDTA clearance. Nephron Clin Pract 2008 ; 108: c284 - c290.
11. Levey AS, Bosch JP, Lewis JB, Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 ; 130: 461-470. (Pubitemid 29135798)
12. Levey AS, Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006 ; 145: 247-254. (Pubitemid 46768608)
13. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006 ; 54: 421-432.
14. Gordon C., Jayne D., Pusey C., et al. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 2009 ; 18: 257-263.
15. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM the Lupus Nephritis Collaborative Study Group. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992 ; 326: 1373-1379.
16. Clough JD, Lewis EJ, Lachin JM and the Lupus Nephritis Collaborative Study Group. Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. In: Rock G (ed.), Progress in Clinical and Biological Research. Vol. 337, New York: Wiley-Liss ; 1990. p. 301-307.
17. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277. (Pubitemid 13221242)
18. Churg J., Bernstein J., Glassock RJ Renal Disease: Classification and Atlas of Glomerular Disease, 2 nd ed. Tokyo: Igaku-Shoin ; 1995. p. 151-155.
19. Schwartz MM, Lan SP, Bonsib SM, Gephardt GN, Sharma HM the Lupus Nephritis Collaborative Study Group. Clinical outcome of three discrete histologic patterns of injury in severe lupus glomerulonephritis. Am J Kidney Dis 1989 ; 13: 273-283. (Pubitemid 19109078)
20. Schwartz MM, Bernstein J., Hill GS, Holley KE, Phillips EA the Lupus Nephritis Collaborative Study Group. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 1989 ; 36: 891-896. (Pubitemid 19283289)
21. Austin HA, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 1983 ; 75: 382-391. (Pubitemid 13005770)
22. Schwartz MM, Lan SP, Bernstein J., Hill GS, Holley KE, Lewis EJ the Lupus Nephritis Collaborative Study Group. Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 1992 ; 42: 743-748.
23. Roberts JL, Lewis EJ Identification of antinative DNA antibodies in cryoglobulinemic states. Am J Med 1978 ; 65: 437-455.
24. Harley JB, Sestak AL, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus. Arthritis Rheum 1989 ; 32: 826-836.
25. Reichlin M. Measurements of antibodies to Sm and nRNP by ELISA: Clinical and serological correlations. In: Kasukawa R, Sharp GC (eds), Mixed Connective Tissue Disease and Autoantibodies. Amsterdam: Elsevier ; 1987. p. 85-96.
26. Stevens LA, Coresh J., Schmid CH, et al. Estimating GFR using serum Cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008 ; 51: 395-406. (Pubitemid 351273480)
27. Kasitanon N., Fine DM, Haas M., Magder LS, Petri M. Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockroft Gault equations. Lupus 2007 ; 16: 887-895. (Pubitemid 350157275)